Immunotherapy plus stereotactic radiation therapy improves event-free survival in early-stage non-small cell lung cancer. . Cancer 2023;129:3680.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Immunotherapy plus stereotactic radiation therapy improves event-free survival in early-stage non-small cell lung cancer. Cancer 2023;129:3680.
PMID: 37921783